Table 6 Observed vs. Predicted EQ-5D Utility by Symptom Group from QLQ-C30 Model
From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
Actual | Predicted (95% CI) | Difference | |
|---|---|---|---|
Symptom group | |||
Asymptomatic | 0.923 | 0.892 (0.816; 0.968) | 0.031 |
Mildly symptomatic | 0.806 | 0.830 (0.780; 0.880) | −0.024 |
Moderately symptomatic | 0.675 | 0.682 (0.617; 0.747) | −0.007 |
Severely symptomatic | 0.501 | 0.476 (0.404; 0.548) | 0.025 |